Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

news

Christopher Nicholas, PhD
News
Psychedelics Show Potential to Improve SUD Treatment Outcomes
10/31/2023
Tom Valentino, Digital Managing Editor
With drug overdose deaths continuing to climb, Sana Symposium presenter Christopher Nicholas, PhD, said studies suggest that incorporating the use of psychedelics into treatment modalities could improve outcomes.
With drug overdose deaths continuing to climb, Sana Symposium presenter Christopher Nicholas, PhD, said studies suggest that incorporating the use of psychedelics into treatment modalities could improve outcomes.
With drug overdose deaths...
10/31/2023
Psych Congress Network
Christopher Nicholas, PhD
News
Psychedelics Show Potential to Improve SUD Treatment Outcomes
10/31/2023
Tom Valentino, Digital Managing Editor
With drug overdose deaths continuing to climb, Sana Symposium presenter Christopher Nicholas, PhD, said studies suggest that incorporating the use of psychedelics into treatment modalities could improve outcomes.
With drug overdose deaths continuing to climb, Sana Symposium presenter Christopher Nicholas, PhD, said studies suggest that incorporating the use of psychedelics into treatment modalities could improve outcomes.
With drug overdose deaths...
10/31/2023
Psych Congress Network
Andrew Penn, RN, PMHNP, and Charles Raison, MD
News
Studies Illustrate Potential of MDMA-, Psilocybin-Assisted Therapies
10/30/2023
Tom Valentino, Digital Managing Editor
Andrew Penn, RN, PMHNP, and Charles Raison, MD, shared findings from late-stage trials for MDMA-assisted therapy to treat post-traumatic stress disorder and the use of psilocybin for treatment-resistant depression and major depressive...
Andrew Penn, RN, PMHNP, and Charles Raison, MD, shared findings from late-stage trials for MDMA-assisted therapy to treat post-traumatic stress disorder and the use of psilocybin for treatment-resistant depression and major depressive...
Andrew Penn, RN, PMHNP, and...
10/30/2023
Psych Congress Network
Single-Dose Psilocybin Linked With Rapid, Sustained Gains in Patients With MDD
News
Single-Dose Psilocybin Linked With Rapid, Sustained Gains in Patients With MDD
09/18/2023
Jolynn Tumolo
A single 25-mg dose of psilocybin plus psychological support was associated with an improvement in depressive symptoms compared with active placebo in adults with MDD, according to a study published in JAMA.
A single 25-mg dose of psilocybin plus psychological support was associated with an improvement in depressive symptoms compared with active placebo in adults with MDD, according to a study published in JAMA.
A single 25-mg dose of...
09/18/2023
Psych Congress Network
News
Experts Share 2 Top Tools for Peer Support in Psychedelics
10/14/2022
Evi Arthur
Techniques to make this therapeutic tool more effective and help build connection with patients.
Techniques to make this therapeutic tool more effective and help build connection with patients.
Techniques to make this...
10/14/2022
Psych Congress Network
News
Lynn-Marie Morski and Rosalind Watts, Most Influential Women in Psychedelics
02/22/2022
Heather Flint, Senior Digital Managing Editor
Sana Symposium Steering Committee Members, Lynn-Marie Morski, MD, JD, and Rosalind Watts, MD, named 2 of the 16 most influential women in the psychedelic space.
Sana Symposium Steering Committee Members, Lynn-Marie Morski, MD, JD, and Rosalind Watts, MD, named 2 of the 16 most influential women in the psychedelic space.
Sana Symposium Steering...
02/22/2022
Psych Congress Network
News
Lynn-Marie Morski and Rosalind Watts, Most Influential Women in Psychedelics
02/22/2022
Heather Flint, Senior Digital Managing Editor
Sana Symposium Steering Committee Members, Lynn-Marie Morski, MD, JD, and Rosalind Watts, MD, named 2 of the 16 most influential women in the psychedelic space.
Sana Symposium Steering Committee Members, Lynn-Marie Morski, MD, JD, and Rosalind Watts, MD, named 2 of the 16 most influential women in the psychedelic space.
Sana Symposium Steering...
02/22/2022
Psych Congress Network
News
Psychedelic-Assisted Therapies are Gaining Ground and Attention
09/29/2021
Heather Flint, Senior Digital Managing Editor
Psychedelic-assisted therapy is an emerging treatment that is gaining traction and attention.
Psychedelic-assisted therapy is an emerging treatment that is gaining traction and attention.
Psychedelic-assisted therapy is...
09/29/2021
Psych Congress Network
News
Psychedelic-Assisted Therapies are Gaining Ground and Attention
09/29/2021
Heather Flint, Senior Digital Managing Editor
Psychedelic-assisted therapy is an emerging treatment that is gaining traction and attention.
Psychedelic-assisted therapy is an emerging treatment that is gaining traction and attention.
Psychedelic-assisted therapy is...
09/29/2021
Psych Congress Network
News
Sana Symposium Recap: New Treatment Potential and Future Possibilities of Psychedelics
09/19/2021
Meagan Thistle
This weekend’s 3-day Inaugural Sana Symposium guided virtual attendees through the preparation, journey, and integration of psychedelic therapies.
This weekend’s 3-day Inaugural Sana Symposium guided virtual attendees through the preparation, journey, and integration of psychedelic therapies.
This weekend’s 3-day Inaugural...
09/19/2021
Psych Congress Network

Advertisement

Advertisement

Advertisement

Popular Now

BHE Podcast, Episode 012 – Steve Millette, Gloo Executive Director
BHE Podcast
BHE Podcast, Episode 012 – Steve Millette, Gloo Executive Director
09/03/2020
Gloo Executive Director Steve Millette joins the BHE Podcast to discuss his organization’s partnership with the Psychiatry & Behavioral Health Learning Network to create the Collaborative Advancement of Recovery Excellence, a recovery...
Gloo Executive Director Steve Millette joins the BHE Podcast to discuss his organization’s partnership with the Psychiatry & Behavioral Health Learning Network to create the Collaborative Advancement of Recovery Excellence, a recovery...
Gloo Executive Director Steve...
09/03/2020
Behavioral Healthcare Executive
News
Janssen Seeks Approval for First 6-Month Long Acting Injectable
11/02/2020
Janssen is seeking US Food and Drug Administration (FDA) approval for the first long-acting injectable (LAI) medication for schizophrenia that would be taken only twice a year.
Janssen is seeking US Food and Drug Administration (FDA) approval for the first long-acting injectable (LAI) medication for schizophrenia that would be taken only twice a year.
Janssen is seeking US Food and...
11/02/2020
Psychiatry & Behavioral Health
Blog
A lesson in brain science for the family
11/02/2015
Exasperated family members and patients deserve accurate answers when they ask, "Why can't they just stop?"
Exasperated family members and patients deserve accurate answers when they ask, "Why can't they just stop?"
Exasperated family members and...
11/02/2015
Addiction Professional
AIMS Severity Assessment Video Library
Diagnostic Tools
AIMS Severity Assessment Video Library
06/12/2021
06/12/2021
Psychiatry & Behavioral Health
News
Telehealth Intervention Eases Symptoms of Anxiety, Depression During COVID-19
06/23/2021
Six weeks after undergoing an online mental health intervention during the COVID-19 pandemic, anxiety and depressive symptoms were significantly lower in patients with a pre-existing medical condition.
Six weeks after undergoing an online mental health intervention during the COVID-19 pandemic, anxiety and depressive symptoms were significantly lower in patients with a pre-existing medical condition.
Six weeks after undergoing an...
06/23/2021
Psych Congress Network

Advertisement

Advertisement

Advertisement

Sign Up

Psychiatry & Behavioral Health Newsletter

Advertisement

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use